Think Tank "Innowacje dla Zdrowia"

Niezależna organizacja wspierająca rozwój medycyny i promocji zdrowia dzięki współpracy z instytutami badawczymi oraz firmami z branży medycznej.

[Maciej Banach @maciejbanach]

Our invited commentary published in the new Dec issue of the #EHJCVP. 🙏 @AgewallStefan for the invitation & @DrPenson for joint work on this!

We will use any occasion to promote SPC as the best way to have our patients on goal and reduce CVD burden.

https://t.co/9ZbfS671r3

[Maciej Banach @maciejbanach]

Our joint recommendations of @PTKardio and @PoLACongress on the #LPA #diagnosis and #management published in the 1/2024 issue of @ArchMedSci as a highly cited paper in the new #ESI report (Jan 2025) by the @Clarivate!

Congratulations to Dr @B_Sosnowska from my team and to all the authors! These recommendations really make a difference but there are many things to be answered on #LPA role and functions. #isoforms #variability #inflammation

[Puls Medycyny @Puls_Medycyny]

Prof. @maciejbanach: fakultatywność całkowicie wypacza ideę #edukacjazdrowotna. Jak mamy być skuteczni w leczeniu społeczeństwa, skoro go nie edukujemy? @MEN_GOVPL @barbaraanowacka @Leszczyna @MZ_GOV_PL
👉https://t.co/th2zPlhpNK

[Maciej Banach @maciejbanach]

Our Expert Opinion article on the extended indications for #fenofibrate in prevention of #cardiovascular #complications, and specifically #retinopathy is a cover article of the new issue of the @ArchMedSci. This was a tremendous work of the experts representing different specializations, including preventing #cardiology, #diabetology, #endocrinology, #familymedicine, #nephrology and #ophthalmology to finally give the physicians attempt of recommendations on how to prevent retinopathy in patients with diabetes and especially how to AVOID retinopathy #complications💪

Few points to remember:
👉In 2021, 529 million people worldwide had #diabetes (average global prevalence: 6.1%).
👉By 2045 the percentage of diabetics worldwide will increase by as much as 46%.
👉Diabetic #retinopathy is one of the major complications of diabetes and is found in up to 30–
40% of patients‼️
👉By 2045, the number of patients with diabetic retinopathy will reach 160.5 million, vision-impairing
retinopathy 44.82 million and significant diabetic macular edema 28.61 million‼️
👉Based on available data we recommend that in patients with type 2 diabetes and a diagnosis of retinopathy, the adding of fenofibrate to statin therapy is recommended to reduce the risk of retinopathy progression, the need for eye surgery and the risk of vision loss.

Thanks and fingers crossed for your effective fight against #retinopathy! @PoLACongress

[Maciej Banach @maciejbanach]

Pewnie pamiętacie nasza analizę, która była jedna z najbadziej cytowanych w światowych mediach (@altmetric score 6280) prac w 2023 roku o roli kroków w wydłużaniu życia, w której powiedzieliśmy, ze dla osób względnie zdrowych, bez choroby sercowo-naczyniowej korzystny efekt zaczyna się od ok. 4000 kroków, z tendencją im więcej tym lepiej, z największym spadkiem śmiertelności pomiędzy 6-13 tys/dziennie‼️

Biorąc pod uwagę ogromne zainteresowanie naukowe i zdrowotne co do roli kroków na parametry zdrowotne (#stresoksydacyjny, #zapalenie, funkcja śródbłonka, #CACScore,# LDL i wiele innych), chcemy kontynuować te badania u osób zarówno z chorobami serca i innymi cywilizacyjnymi, po incydentach, ale także u tych, którzy robią średnia liczbę kroków więcej niż 👉20,000/dziennie, ponieważ nasze i inne badania nie pozwalają na wnioskowanie co do znaczenia tej liczy kroków na zdrowie (wskazują na brak dalszej korzyści zdrowotnej od 16 tys kroków).

Stad jeśli bylibyście zainteresowani by wziąć udział w takich badaniach - serdecznie zapraszam i proszę o kontakt na priv. 💪

[Maciej Banach @maciejbanach]

IMPORTANT from the new issue of @ArchMedSci: 2024 Polish #recommendations for the #management of #familial #hypercholesterolemia #FH in #children and #adolescents.

The most important recommendations:
👉 It is advisable to use direct #LDL #cholesterol #measurement for improved accuracy.
👉 #LPA levels should be measured in all children suspected of FH. If LDL-C is calculated using the #Friedewald formula, this value should be adjusted for the Lp(a) result.
👉 Early diagnosis at 5 years of age is recommended‼️Consequently, this expert panel supports implementing lipid profile universal #screening during preventive healthcare visits at the age of 6‼️
👉 Patients and their families should be supported by multidisciplinary care #teams comprising specialized #healthcare #professionals, including a specialist #physician, #psychologist, #dietitian, and #nursing staff. #Genetic consultation is also advisable.
👉 #Dietary #intervention should be implemented for every child with #dyslipidemia starting from the age of 2.
👉 #Statin #therapy should be considered for children aged 6–10 years.
👉 Despite using the maximum dose of #statins, achieving the LDL-C #goals may be challenging. In this case, it is advised to introduce #ezetimibe (from the age of 10 years), which inhibits cholesterol absorption in the intestines and complements the effects of statins.

Congratulations to the whole team beautifully led by prof. #MalgorzataMysliwiec from the @GUMedGdansk ‼️👏👏

https://t.co/bxBHKQIYNK

[Maciej Banach @maciejbanach]

Great meeting of the @worldheartfed #cholesterol #expert group aimed to evaluate the global capacity for #lipiddisorders #diagnosis and #therapy, #gaps and #opportunities for improvement and to provide insight and best examples for #policymakers and #health #organizations (with the special emphasis to #LMIC) to change the situation that lipid disorders are the most prevalent (even 70% of population), worst monitored (only 15% of people are aware of them), and worst treated risk factor (only about 20-25% on goal).

Amazing meeting led by the prof. @rauldsf_santos. Thanks and looking forward for the next steps💪

[Maciej Banach @maciejbanach]

Feel invited to join us at the 4th World Congress of Clinical Lipidology in Vienna! @lipiddoctor

[Maciej Banach @maciejbanach]

The results of our data from the #PMMHRI-#LPA #Registry and #STAR-#LPA study that were presented at the @escardio #congress in London again beautifully summarized in the @MSN. Thanks!

https://t.co/GLeYgzq9Jm

[Maciej Banach @maciejbanach]

Wszyscy na początku roku robią podsumowanie roku. Ja chciałbym zacząć od #wysiłekfizyczny, który jak doskonale wiecie tak bardzo promuję jako najskuteczniejsza tabletkę przedłużająca życie 🚴‍♀️❤️

Rok 2024 był dla mnie rokiem pełnym wyzwań, ogromnej liczby wyjazdów i aktywności, ale jednak udało mi się mieć regularny (prawie codzienny‼️) wysiłek fizyczny (głównie jako chodzenie🚶, bieganie🏃‍♂️ oraz jazda na rowerze stacjonarnym🚴‍♂️).

Co udało mi się zatem osiągnąć w roku 2024, z mocnym postanowieniem na jeszcze lepsze wyniki w roku 2025:
👉średnia dzienna liczba kroków to 10527 (19% wzrost w stosunku do roku 2023)! #kroki #steps
👉 liczba przebiegniętych km 321 (średnia miesięczna 27 km) - ponad 2-krotna poprawa (plan na 2025 - to 500 km)! #run
👉 liczba minut intensywnej aktywności - 313 min tygodniowo - kolejny wzrost o ponad 10%
- udało się tez ustanowić kilka rekordów, w tym na 5 km oraz najwieksza liczba kroków tygodniowo i miesięcznie💪.

Zdaje sobie sprawę, ze te wyniki dla wielu z Was nie są żadnym wyzwaniem (gratulacje i podziw dla Was👏), ale pokazuje je by powiedzieć, że warto mieć regularny wysiłek fizyczny oraz by potwierdzić, ze to nie tylko dane naukowe, które w tym aspekcie są jednoznaczne‼️, jeśli chodzi o dobroczynny wpływ wysiłku na zdrowie (poza wysiłkiem ekstremalnym), ale także moje własne doświadczenie dobroczynnego wpływu wysiłku, które staram się Wam przekazywać. Dla mnie to także najlepsza tabletka na stres - polecam codziennie, bez względu na porę dnia 🤪

Niech rok 2025 będzie dla Was rokiem zdrowia z regularnym wysiłkiem fizycznym, takim jaki lubicie💪 Powodzenia, trzymam kciuki, cudownego roku 2025‼️

[Maciej Banach @maciejbanach]

Beginning of the year is also great time to summarize the year in the Archives of Medical Science #journal (@ArchMedSci) I funded 20 years ago💪

It was indeed a record year for #AMS:
1. Based on the JCR2023 the journal is for the first time a Q1 journal ranked for IF and journal citation index.
2. in 2024 we processed 2135 papers (‼️), of which 1392 papers were rejected with only 218 papers accepted (#rejectionrate: 86.46%; for research papers we accept only 1/10 submission and for review ones
less than 1/4).
3. In 2024 five of the most popular scientific areas of submitted papers were: public health, molecular biology, oncology, neurology and immunology.
4. The most cited 2024 paper is: "Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels" (https://t.co/jYIQRaGmhh)
5. The 2024 paper with the best Attention Score by the @altmetric is: "Lipoprotein(a) and its impact on cardiovascular disease – the Polish perspective: design and first results of the Zabrze-Lipoprotein(a) Registry" (https://t.co/kyBbxZduAx)

Let's hope also IF2024 will reflect the hard work we all dedicate to the journal 💪

I would like to kindly thank to all the @TermediaPL Editors, especially Beata, Marzena and Donata, as well as all the Editors of the Archives of Medical Science: @karelallegaert, @AssadiMajidMD, @claudiabonini23, @accovic, @DhasmanaAnupam, @FilippatosTheo, @Mojgannn22161, @sgoto4, @JingHeMD, @KraljIglic, @LenassiMetka, @analleo, @thn_thomas, @Nikolic7Dr, @IonuNistor, @NPAPANAS, @reddyparine, @PanagiotisPeit1, @GabrielePiffar1, @syedtabishrehma, @SABOURETCardio, @ConsolatoSergi, @shantsila, @stanislawsurma, @ParhamTaslimi, @Ran_Wang_UoM, @Pingzheng7, @josef_veselka, @niels_voigt, @JiexiongX, @jackey890819, @ilhanyaylim2, @DoctorZtweets, @Hongliangcc, @shwetas90553192, @LuigiSpadafora, @Chigir6, @MarlenaKSu, @CarlLavie31733

[Maciej Banach @maciejbanach]

Amazing collaborative paper with Prof. Bojko Bjelakovic from Nis, Serbia with his team, and Prof. Claudia Stefanutti from Rome, Italy on the Relationship Between Ambulatory Blood Pressure #ABM and #Atherogenic #Index #AIP with LV Geometry Pattern in #Obese #Children. (mean age 14.2 years) has just been published in the Pediatric Cardiology by @SpringerNature.

We showed that AIP and #age are independently associated with the presence of concentric left ventricular geometry with girls seeming more protected from atherogenic hypertrophic stimulus than boys. #BMI and sex are independently associated with eccentric left ventricular remodeling, with BMI being a greater risk factor for girls.

https://t.co/CJ3Z1IVEov

[Maciej Banach @maciejbanach]

A Global Cardiovascular Collaborative Network of Older Adults with Cardiovascular Disease (The #GLOBcAGE #Consortium) is now a fact‼️

Great thanks to @AngelaSKoh1 for starting and leading this! It is very challengeable, but I am sure that we will succeed, especially we need more and more good #data on #cardiovascular #riskfactors and #ACVD data in elderly patients.

Stay tuned for more information💪

https://t.co/m9LYAJEMbd

[Maciej Banach @maciejbanach]

A jednak moje miasto rodzinne o mnie pamięta‼️🥰 Ja nigdy nie zapominam swoich korzeni; to były piękne lata spędzone w Szkole Podstawowej nr 2 na Międzytorzu oraz w kochanym Liceum im. Władysława Jagiełły❤️ @portalplock @WyborczaPlock @prezydentplocka

https://t.co/nGmsi2AM7r

[Maciej Banach @maciejbanach]

(...) just know, you will never be enough, but you can do a value of your work if you just put down a measuring stick (...). Love it ❤️ @justdemi

[Maciej Banach @maciejbanach]

Our continuous effort to promote #combination #therapies, preferably #SPC/#FDC, as a way for more effective #CVD #prevention, ensuring early #goal achievement, better #adherence, less #sideeffects and significant reduction of #CVD #outsomes.

This time, within the group of Polish #Experts under the umbrella of the Polish Lipid Association #PoLA (@PoLACongress) we tackled the topic of the SPC combination therapy based on #rosuvastatin with #ezetimibe or #aspirin (available in Poland), to practically show the group of #patients that might benefit from the most. We also clearly emphasized that for many patients at the CVD #risk, there might be an overlapping of the #indications, and the final decision will be a part of the personalized approach. #personalization

Thanks to all the amazing Experts working with me for last several months‼️💪 @FilipMSzymanski

https://t.co/CvMpMaep1n

[Maciej Banach @maciejbanach]

Today I have had some time to play with the @grok #GROK. In my opinion it is much, much better than #ChatGPT, as as an AI-tool uses many sources, have well-thought conclusions and even hypothesize.

Taking into account that in next 22 hours days we start 2025, which is the 10th Anniversary of the #ILEP @ExpertLipid (gosh amazing, I remember 2015, when I started work at the ILEP), I also asked #GROK about the ILEP.

👉"In summary, ILEP plays a crucial role in advancing the understanding and #management of #lipiddisorders, influencing both #research and clinical #practice through their expert #recommendations, educational efforts and collaborative #projects". 💪

I do like the response, which is the confirmation that we are doing good things for the preventive cardiology, atherosclerosis and lipids both in the in the patient and physician dimensions. 👉Thank you to all ILEP members and Friends for these joint 10 years of amazing #collaboration! 🥰

[Maciej Banach @maciejbanach]

Have a great New Year's Eve #party and a beautiful, successful New Year A.D. 2025 always based on great, open cooperation🥰💪 @PoLACongress @ExpertLipid @IHME_UW @NCD_RisC @KUL_Lublin @umedlodz @LiverpoolCCS @CiccaroneCenter @hopkinsheart @nomibiotech @GraylightImging @ArchMedSci @JCM_MDPI @ehjopen

[Puls Medycyny @Puls_Medycyny]

🫀Uznaliśmy, że już 30-50 mg/dl lipoproteiny(a) stwarza umiarkowane ryzyko SN. Duże ryzyko obejmuje wartości od 50 do 180 mg/dl, a bardzo duże - powyżej 180 mg/dl - mówi prof. @maciejbanach, przedstawiając rekomendacje @PoLACongress z 2⃣0⃣2⃣4⃣ r.
https://t.co/7H4UD2vFPS